aTyr Pharma Inc
NASDAQ:ATYR

Watchlist Manager
aTyr Pharma Inc Logo
aTyr Pharma Inc
NASDAQ:ATYR
Watchlist
Price: 5.245 USD -14.85% Market Closed
Market Cap: 466.8m USD

EV/FCFF
Enterprise Value to FCFF

-6.3
Current
-0.3
Median
4.2
Industry
Lower than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-6.3
=
Enterprise Value
391.2m USD
/
FCFF
-62.2m USD
Market Cap EV/FCFF
US
aTyr Pharma Inc
NASDAQ:ATYR
466.8m USD -6.3
FR
Pharnext SCA
OTC:PNEXF
6T USD -215 089.7
US
Abbvie Inc
NYSE:ABBV
337.7B USD 25.9
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
325.9B USD -14 474
US
Amgen Inc
NASDAQ:AMGN
163.2B USD 19.1
US
Gilead Sciences Inc
NASDAQ:GILD
142.2B USD 16.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.4B USD -90.8
US
Epizyme Inc
F:EPE
94.1B EUR -521.4
AU
CSL Ltd
ASX:CSL
133.2B AUD 50.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
60.4B USD 18.5
US
Seagen Inc
F:SGT
39.3B EUR -63.1
 
US
aTyr Pharma Inc
NASDAQ:ATYR
Average EV/FCFF: 26.1
Negative Multiple: -6.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -215 089.7
US
Abbvie Inc
NYSE:ABBV
25.9
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
Negative Multiple: -14 474
US
Amgen Inc
NASDAQ:AMGN
19.1
US
Gilead Sciences Inc
NASDAQ:GILD
16.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -90.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.4
AU
CSL Ltd
ASX:CSL
50.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -63.1

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Summary
ATYR intrinsic value, competitors valuation, and company profile.
DCF Valuation
ATYR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ATYR stock valuation using valuation multiples.
Wall Street Estimates
ATYR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ATYR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 271,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.